TGFB1 and pulmonary fibrosis: These findings revealed that MLB, mainly by inhibiting the TGF-βRI and Smad signaling pathways, had partial anti-fibrosis effects of the TGF-β inhibitor and showed good efficacy in the medical treatment of pulmonary fibrosis.